Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 1997

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Squamous Cell CarcinomaCarcinoma of Head/Neck
Interventions
DRUG

Taxotere

DRUG

Cisplatin

DRUG

5-Fluorouracil

DRUG

Leucovorin

DRUG

G-CSF

DRUG

Ciprofloxacin

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

02115

Dana-Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

Sanofi

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER